Bristol-Myers Squibb Company Ce
Bristol-Myers Squibb Company Ce (CELG-RI) Stock Forecast & Price Predictions
Get the latest Bristol-Myers Squibb Company Ce (CELG-RI) stock forecast across short-term and long-term horizons. Meyka AI generates price predictions using advanced models trained on historical data. These forecasts are not investment advice but directional insights to help investors and traders plan strategies.
Model Information
The Forecast Prediction Model is provided for informational purposes only and should not be considered financial advice. We are continously improving this model to increase accuracy and performance.Read our Full DisclaimerMonthly Forecast
Quarterly Forecast
Yearly Forecast
3 Years Forecast
5 Years Forecast
7 Years Forecast
Bristol-Myers Squibb Company Ce Stock Forecast Summary
Bristol-Myers Squibb Company Ce (CELG-RI) stock is currently priced at $0.09. Based on Meyka AI predictions, the short-term outlook is bullish, with momentum pointing higher. The 1-month projection suggests a move toward $0.09.
In the long term, CELG-RI shows a bearish trend. The 2027 forecast points to $0.08 (-3.33% change), while the 2031 forecast suggests $0.16 (86.36% change). Looking 7 years ahead, projections estimate the stock could trade near $0.21, a 142.14% change from today’s price.
Neutral
Bullish
Bearish
This mix indicates that Bristol-Myers Squibb Company Ce stock is expected to trade sideways over the coming years.
Bristol-Myers Squibb Company Ce yearly Price Forecast Chart
Explore the yearly forecast chart for CELG-RI, which maps expected price movement, support levels, and resistance targets. The dropdown lets you view forecasts across multiple horizons, from short-term daily trends to 7-year projections, helping investors evaluate Bristol-Myers Squibb Company Ce over different timeframes.
No forecast data available
No prediction data found for this time period.
Forecasting data is not available for CELG-RIForecasting details for CELG-RI are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.Bristol-Myers Squibb Company Ce Stock Forecast 2026
The forecast for Bristol-Myers Squibb Company Ce (CELG-RI) in 2026 suggests a price of $0.08, representing a -3.33% move from today’s price.
Average Target: $0.08
Market Outlook: bearish based on current trend indicators.
Key Drivers in 2026:- Earnings growth projections.
- Competitive performance in the Healthcare.
- Macroeconomic factors such as interest rates and inflation.
Bristol-Myers Squibb Company Ce Stock Forecast 2030
By 2030, Meyka AI projects CELG-RI could trade near $0.16, showing a potential 86.36% compared to current levels.
Average Target: $0.16
Market Outlook: bullish.
What could influence the 2030 forecast:- Technological innovation and product cycles.
- Expansion into global markets.
- Long-term investor sentiment toward Bristol-Myers Squibb Company Ce.
Bristol-Myers Squibb Company Ce 7-Year Stock Forecast (2032–2033)
Looking 7 years ahead, the long-term forecast for CELG-RI points to a price around $0.21, which is a projected 142.14% move from today’s level.
Average Target: $0.21
Outlook: bullish, depending on macroeconomic conditions and sector growth.
Long-Term Drivers:- Global economic expansion or contraction.
- Regulatory and policy environment.
- Bristol-Myers Squibb Company Ce’s ability to maintain market leadership.